Ondansetron-Teva 4 oro, Schmelztabletten - 10 Tablette(n) Swissmedic Key 58219003 Registration Holder Teva Pharma AG Name Ondansetron-Teva 4 oro, Schmelztabletten Date of registration 17.04.2008 Original/Generic Generic Introduction of Sequence 04.03.2010 ATC-Classification Ondansetron (A04AA01) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.09. Show package size 10 Tablette(n) Index Therapeuticus (Swissmedic) 01.09. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 22.60 Limitation Yes Limitation text
Deductible 10 % Consumer price 40.95 Feedback FB Daily cost GTIN 7680582190035 Medication Code Synthetika Pharmacode 6347070 Disponibility
Composition ondansetronum 4 mg, magnesii stearas, lactosum monohydricum 55.906 mg, hydroxypropylcellulosum substitutum humile, crospovidonum, calcii silicas, silica colloidalis anhydrica, aromatica (Pfefferminz) aspartamum 994 µg, pro compresso. Packungsbestandteile Galenic Form Melting tablets Active Agent Dose Ondansetron 4 mg
BAG: Active Agent Dose Ondansetron 4 mg
Inactive agents Dose Aromatica (Pfefferminz) Aspartamum 994 µg Calcii Silicas Crospovidonum Hydroxypropylcellulosum Substitutum Humile Lactose Monohydrate 55.906 mg Magnesii Stearas Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 02.09.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
